Peroxiredoxin 2 overexpression protects cortical neuronal cultures from ischemic and oxidative injury but not glutamate excitotoxicity, whereas Cu/Zn superoxide dismutase 1 overexpression protects only against oxidative injury

Journal of Neuroscience Research

Volumn 85, Issue 14, 2007, Pages 3089-3097

  Boulos, Sherif ^a,c   Meloni, Bruno P ^a,b   Arthur, Peter G ^a   Bojarski, Christina ^a,b   Knuckey, Neville W ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Adenovirus; Cumene hydroperoxide; In vitro; Neuroprotection; Oxygen glucose deprivation

Indexed keywords

ADENOVIRUS VECTOR; COPPER ZINC SUPEROXIDE DISMUTASE; CUMENE HYDROPEROXIDE; GLUCOSE; GLUTAMIC ACID; OXYGEN; PEROXIREDOXIN; PEROXIREDOXIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN HYPOXIA; BRAIN ISCHEMIA; CONTROLLED STUDY; EMBRYO; EXCITOTOXICITY; HIPPOCAMPUS; HUMAN; HUMAN CELL; HYPOGLYCEMIA; IN VITRO STUDY; MALE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANALYSIS OF VARIANCE; ANIMALS; BENZENE DERIVATIVES; CELL COUNT; CELLS, CULTURED; CEREBRAL CORTEX; DRUG INTERACTIONS; EMBRYO, MAMMALIAN; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; ISCHEMIA; ISCHEMIC PRECONDITIONING; NEURONS; OXIDANTS; OXIDATION-REDUCTION; PEROXIREDOXINS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 35848954507     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21429     Document Type: Article

References (65)

1. Arthur PG, Lim SC, Meloni BP, Munns SE, Chan A, Knuckey NW. 2004. The protective effect of hypoxic preconditioning on cortical neuronal cultures is associated with increases in the activity of several antioxidant enzymes. Brain Res 1017:146-154.
2. Barkats M, Bemelmans AP, Geoffroy MC, Robert JJ, Loquet I, Horellou P, Revah F, Mallet J. 1996. An adenovirus encoding CuZnSOD protects cultured striatal neurones against glutamate toxicity. Neuroreport 7:497-501.
3. Barkats M, Millecamps S, Bilang-Bleuel A, Mallet J. 2002. Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine. J Neurochem 82:101-109.
4. Barkats M, Horellou P, Colin P, Millecamps S, Faucon-Biguet N, Mallet J. 2006. 1-Methyl-4-phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase. J Neurosci Res 83:233-242.
5. Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M. 2004. Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 4:3943-3952.
6. Borg J, London J. 2002. Copper/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro. J Neurosci Res 70:180-189.
7. Boulos S, Meloni BP, Arthur PG, Bojarski C, Knuckey NW. 2006. Assessment of CMV, RSV and SYN1 promoters and the woodchuck posttranscriptional regulatory element in adenovirus vectors for transgene expression in cortical neuronal cultures. Brain Res 1102:27-38.
8. Boulos S, Meloni BP, Arthur PG, Majda B, Bojarski C, Knuckey NW. 2007. Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury. Neurobiol Dis 25:54-64.
9. Bryk R, Griffin P, Nathan C. 2000. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407:211-215.
10. Chae HZ, Robison K, Poole LB, Church G, Storz G, Rhee SG. 1994. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci U S A 91:7017-7021.
11. Chan PH, Chu L, Chen SF, Carlson EJ, Epstein CJ. 1990. Attenuation of glutamate-induced neuronal swelling and toxicity in transgenic mice overexpressing human CuZn-superoxide dismutase. Acta Neurochir Suppl 51:245-247.
12. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, Kang SW. 2005. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435:347-353.
13. Chung YM, Yoo YD, Park JK, Kim YT, Kim HJ. 2001. Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res 21:1129-1133.
14. Dirnagl U, Simon RP, Hallenbeck JM. 2003. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 26:248-254.
15. Fujii JI, Ikeda Y. 2002. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 7:123-130.
16. Gavino VC, Miller JS, Ikharebha SO, Milo GE, Cornwell DG. 1981. Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures. J Lipid Res 22:763-769.
17. Goldner FM, Patrick JW. 1996. Neuronal localization of the cyclophilin A protein in the adult rat brain. J Comp Neurol 372:283-293.
18. Halliwell B, Guderidge JMC. 1999. Free radicals in biology and medicine. Oxford Univ Press, 3rd ed., Oxford, UK.
19. Hattori F, Murayama N, Noshita T, Oikawa S. 2003. Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. J Neurochem 86:860-868.
20. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. 1998. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95:2509-2514.
21. Hu BR, Martone ME, Jones YZ, Liu CL. 2000. Protein aggregation after transient cerebral ischemia. J Neurosci 20:3191-3199.
22. Ichimiya S, Davis JG, O'Rourke DM, Katsumata M, Greene MI. 1997. Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury. DNA Cell Biol 16:311-321.
23. Jang HH, Lee KO, Chi YH, Jung BG, Park SK, Park JH, Lee JR, Lee SS, Moon JC, Yun JW, Choi YO, Kim WY, Kang JS, Cheong GW, Yun DJ, Rhee SG, Cho MJ, Lee SY. 2004. Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function. Cell 117:625-635.
24. Jaschke A, Mi H, Tropschug M. 1998. Human T cell cyclophilin18 binds to thiol-specific antioxidant protein Aop1 and stimulates its activity. J Mol Biol 277:763-769.
25. Jin MH, Lee YH, Kim JM, Sun HN, Moon EY, Shong MH, Kim SU, Lee SH, Lee TH, Yu DY, Lee DS. 2005. Characterization of neural cell types expressing peroxiredoxins in mouse brain. Neurosci Lett 381:252-257.
26. Kaku DA, Giffard RG, Choi DW. 1993. Neuroprotective effects of glutamate antagonists and extracellular acidity. Science 260:1517-1518.
27. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. 1998. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 273:6297-6302.
28. Kang SW, Chang TS, Lee TH, Kim ES, Yu DY, Rhee SG. 2004. Cytosolic peroxiredoxin attenuates the activation of Jnk and p38 but potentiates that of Erk in Hela cells stimulated with tumor necrosis factor-alpha. J Biol Chem 279:2535-2543.
29. Kato S, Kato M, Abe Y, Matsumura T, Nishino T, Aoki M, Itoyama Y, Asayama K, Awaya A, Hirano A, Ohama E. 2005. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models. Acta Neuropathol 110:101-112.
30. Kim H, Lee TH, Park ES, Suh JM, Park SJ, Chung HK, Kwon OY, Kim YK, Ro HK, Shong M. 2000. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 275:18266-18270.
31. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, et al. 1990. "Ischemic tolerance" phenomenon found in the brain. Brain Res 528:21-24.
32. Koh JY, Choi DW. 1991. Selective blockade of non-NMDA receptors does not block rapidly triggered glutamate-induced neuronal death. Brain Res 548:318-321.
33. Koster JF, Slee RG. 1983. Lipid peroxidation of human erythrocyte ghosts induced by organic hydroperoxides. Biochim Biophys Acta 752:233-239.
34. Krapfenbauer K, Engidawork E, Cairns N, Fountoulakis M, Lubec G. 2003. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res 967:152-160.
35. Kristensen P, Rasmussen DE, Kristensen BI. 1999. Properties of thiolspecific anti-oxidant protein or calpromotin in solution. Biochem Biophys Res Commun 262:127-131.
36. Lee JP, Palfrey HC, Bindokas VP, Ghadge GD, Ma L, Miller RJ, Roos RP. 1999. The role of immunophilins in mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 96:3251-3256.
37. Lee SP, Hwang YS, Kim YJ, Kwon KS, Kim HJ, Kim K, Chae HZ. 2001. Cyclophilin a binds to peroxiredoxins and activates its peroxidase activity. J Biol Chem 276:29826-29832.
38. Matsumoto A, Okado A, Fujii T, Fujii J, Egashira M, Niikawa N, Taniguchi N. 1999. Cloning of the peroxiredoxin gene family in rats and characterization of the fourth member. FEBS Lett 443:246-250.
39. Matsumoto G, Stojanovic A, Holmberg CI, Kim S, Morimoto RI. 2005. Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J Cell Biol 171:75-85.
40. Matsumoto K, Lo EH, Pierce AR, Halpern EF, Newcomb R. 1996. Secondary elevation of extracellular neurotransmitter amino acids in the reperfusion phase following focal cerebral ischemia. J Cereb Blood Flow Metab 16:114-124.
41. Meloni BP, Majda BT, Knuckey NW. 2001. Establishment of neuronal in vitro models of ischemia in 96-well microtiter strip-plates that result in acute, progressive and delayed neuronal death. Neuroscience 108:17-26.
42. Meloni BP, Majda BT, Knuckey NW. 2002. Evaluation of preconditioning treatments to protect near-pure cortical neuronal cultures from in vitro ischemia induced acute and delayed neuronal death. Brain Res 928:69-75.
43. Meloni BP, Tilbrook PA, Boulos S, Arthur PG, Knuckey NW. 2006. Erythropoietin preconditioning in neuronal cultures: signaling, protection from in vitro ischemia, and proteomic analysis. J Neurosci Res 83:584-593.
44. Michaels RL, Rothman SM. 1990. Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. J Neurosci 10:283-292.
45. 2-induced cell death. J Biol Chem 280:28775-28784.
46. + transport in erythrocyte membrane vesicles requires a cytoplasmic protein. J Biol Chem 266:18964-18968.
47. O'Neil BJ, McKeown TR, DeGracia DJ, Alousi SS, Rafols JA, White BC. 1999. Cell death, calcium mobilization, and immunostaining for phosphorylated eukaryotic initiation factor 2-alpha (eIF2alpha) in neuronally differentiated NB-104 cells: arachidonate and radical-mediated injury mechanisms. Resuscitation 41:71-83.
48. Persoon-Rothert M, Egas-Kenniphaas JM, van der Valk-Kokshoorn EJ, van der Laarse A. 1992. Cumene hydroperoxide induced changes in calcium homeostasis in cultured neonatal rat heart cells. Cardiovasc Res 26:706-712.
49. Pringle AK, Thomas SJ, Signorelli F, Iannotti F. 1999. Ischemic pre-conditioning in organotypic hippocampal slice cultures is inversely correlated to the induction of the 72 kDa heat shock protein (HSP72). Brain Res 845:152-164.
50. Prosperi MT, Ferbus D, Rouillard D, Goubin G. 1998. The pag gene product, a physiological inhibitor of c-abl tyrosine kinase, is overexpressed in cells entering S phase and by contact with agents inducing oxidative stress. FEBS Lett 423:39-44.
51. Rand JD, Grant CM. 2006. The thioredoxin system protects ribosomes against stress-induced aggregation. Mol Biol Cell 17:387-401.
52. Sánchez-Font MF, Sebastia J, Sanfeliu C, Cristofol R, Marfany G, Gonzalez-Duarte R. 2003. Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains. Cell Mol Life Sci 60:1513-1523.
53. Sarafian TA, Verity MA, Vinters HV, Shih CC, Shi L, Ji XD, Dong L, Shau H. 1999. Differential expression of peroxiredoxin subtypes in human brain cell types. J Neurosci Res 56:206-212.
54. Schroder E, Willis AC, Ponting CP. 1998. Porcine natural-killer-enhancing factor-B: oligomerisation and identification as a calpain substrate in vitro. Biochim Biophys Acta 1383:279-291.
55. Schroder E, Jonsson T, Poole L. 2003. The role of erythrocyte peroxiredoxin in detoxifying peroxides and in stimulating potassium efflux via the Gardos channels. Blood 101:2897-2898.
56. Simzar S, Ellyin R, Shau H, Sarafian TA. 2000. Contrasting antioxidant and cytotoxic effects of peroxiredoxin I and II in PC12 and NIH3T3 cells. Neurochem Res 25:1613-1621.
57. 2+ concentrations. J Neurochem 66:2057-2066.
58. + load and oxidative stress in nerve terminals: relevance to ischemia/reperfusion. J Neurochem 83:855-862.
59. Tsai MC, Chen YH, Chiang LY. 1997. Polyhydroxylated C60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide-elicited changes in rat hippocampus in-vitro. J Pharm Pharmacol 49:438-445.
60. Vroegop SM, Decker DE, Buxser SE. 1995. Localization of damage induced by reactive oxygen species in cultured cells. Free Radic Biol Med 18:141-151.
61. Wood ZA, Schroder E, Robin Harris J, Poole LB. 2003. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28:32-40.
62. Ying W, Anderson CM, Chen Y, Stein BA, Fahlman CS, Copin JC, Chan PH, Swanson RA. 2000. Differing effects of copper, zinc superoxide dismutase overexpression on neurotoxicity elicited by nitric oxide, reactive oxygen species, and excitotoxins. J Cereb Blood Flow Metab 20:359-368.
63. Zeng M, Smith SK, Siegel F, Shi Z, Van Kampen KR, Elmets CA, Tang DC. 2001. AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination. Biotechniques 31:260-262.
64. Zhang P, Liu B, Kang SW, Seo MS, Rhee SG, Obeid LM. 1997. Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem 272:30615-30618.
65. Zhu H, Meloni BP, Moore SR, Majda BT, Knuckey NW. 2004. Intravenous administration of magnesium is only neuroprotective following transient global ischemia when present with post-ischemic mild hypothermia. Brain Res 1014:53-60.